Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
![]() |
Gilead SciencesGILD |
$8,000 |
![]() |
AmgenAMGN |
-$75,000 |
![]() |
Editas MedicineEDIT |
-$8,000 |
![]() |
United TherapeuticsUTHR |
-$210,000 |
![]() |
RegeneronREGN |
$24,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Christopher Jacobs Republican | Nov 8, 2022 | Sell | $1K - $15K |
Who is the latest politician to buy or sell Ocugen shares?
Christopher Jacobs sold Ocugen shares most recently on November 8, 2022.
Which politician has sold the most OCGN stock over the last two years?
Christopher Jacobs has sold the most OCGN stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading OCGN stock in the last 2 years?
The net value of trades by US politicians for Ocugen in the last 2 years is negative, amounting to -$8,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on Ocugen's market confidence?
Over the last 2 years, insider transactions for Ocugen have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.